All In Biotech

Drug Trial Radar · NCT05552976

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2

Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 606 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

606

Actual

Start

Jan 10, 2023

Primary completion

Sep 28, 2026

Study completion Jul 25, 2029

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Sep 23, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.

Conditions

  • Relapsed or Refractory Multiple Myeloma

Interventions

  • MezigdomideDrug

    Specified dose on specified days

  • CarfilzomibDrug

    Specified dose on specified days

  • DexamethasoneDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS)Time frame: Up to approximately 5 years

Locations

204 sites in 27 countries. Site status is shown where the registry gives one.

  • Local Institution - 0046

    Mobile, Alabama

  • Local Institution - 0005

    Cerritos, California

  • Local Institution - 0190

    Irvine, California

  • Local Institution - 0187

    Los Angeles, California

  • Local Institution - 0344

    Santa Rosa, California

  • Local Institution - 0339

    Stockton, California

  • Local Institution - 0341

    Fort Myers, Florida

  • Local Institution - 0342

    St. Petersburg, Florida

  • Local Institution - 0340

    West Palm Beach, Florida

  • Local Institution - 0348

    Atlanta, Georgia

  • Local Institution - 0291

    Atlanta, Georgia

  • Saint Alphonsus Regional Medical Center

    Boise, Idaho

  • Local Institution - 0289

    Annapolis, Maryland

  • Local Institution - 0204

    Boston, Massachusetts

  • Local Institution - 0346

    Minneapolis, Minnesota

  • Local Institution - 0222

    Little Silver, New Jersey

  • Local Institution - 0199

    The Bronx, New York

  • Local Institution - 0322

    Cleveland, Ohio

  • Local Institution - 0172

    Columbus, Ohio

  • Local Institution - 0321

    Providence, Rhode Island

  • Local Institution - 0338

    Greer, South Carolina

  • Local Institution - 0349

    Chattanooga, Tennessee

  • Local Institution - 0323

    Nashville, Tennessee

  • Local Institution - 0337

    Fort Worth, Texas

  • Local Institution - 0328

    Houston, Texas

  • Local Institution - 0044

    Houston, Texas

  • Local Institution - 0195

    Temple, Texas

  • Local Institution - 0345

    Norfolk, Virginia

  • Local Institution - 0343

    Roanoke, Virginia

  • Local Institution - 0006

    Tacoma, Washington

  • Local Institution - 0347

    Vancouver, Washington

  • Local Institution - 0243

    Morgantown, West Virginia

  • Local Institution - 0336

    Marshfield, Wisconsin

  • Local Institution - 0150

    Buenos Aires, Argentina

  • Local Institution - 0151

    Córdoba, Argentina

  • Local Institution - 0008

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

  • Local Institution - 0079

    ABB, Buenos Aires F.D., Argentina

  • Local Institution - 0182

    Rosario, Santa Fe Province, Argentina

  • Local Institution - 0319

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Local Institution - 0077

    Camperdown, New South Wales, Australia

Showing 40 of 204 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.